Research by Dr. John Ringman, Associate Professor of Neurology and a member of UCLA's Mary S. Easton Center for Alzheimer's Disease Research, commented May 15 on ABCNews.com about an experimental drug for Alzheimer's disease in a specific population. He was also quoted May 15 by KABC-Channel 7 on the same topic. The Easton Center is currently conducting a clinical trial of the medication that will be tested in this unique prevention study. - Study of an Antibody Treatment for Alzheimer's Disease.
Article by Pam Belluck/The New York Times: "New Drug Trial Seeks to Stop Alzheimer's Before It Starts"